FDA Approves New Shingles Vaccine: Shingrix
A new shingles vaccine will dramatically reduce your chances of developing the painful condition.
On Oct. 20, 2017, the U.S. Food and Drug Administration (FDA) approved Shingrix for adults 50 and older to prevent shingles, also known as zoster or herpes zoster. The research shows that it is more than 97 percent effective compared to a placebo.